An analyst at Monness, Crespi, Hardt downgraded shares of Momenta Pharmaceuticals from Buy to Neutral in an intraday note today. The stock dipped in mid-day trading as the downgrade began hitting wires, however shares seem to be bouncing. Anyone have the report that they could post? TIA. 10nis